Literature DB >> 3030414

Dual pathways in muscarinic receptor stimulation of phosphoinositide hydrolysis.

D Gurwitz, M Sokolovsky.   

Abstract

The relationships between phosphoinositide hydrolysis induced by various muscarinic agonists and by membrane depolarization agents were investigated in rat cerebral cortex and heart atrium slices. In both preparations, phosphoinositide hydrolysis was stimulated by a combination of carbamylcholine and membrane depolarization with 40 mM K+ in a synergistic fashion. The synergism was more pronounced at lower external calcium ion concentrations and was sensitive to verapamil. Lower external calcium ion concentrations were required for demonstration of the synergism in heart atrium slices than in cerebral cortex slices. The carbamylcholine-induced stimulation was only partially additive with membrane depolarization via Na+ channel gating by batrachotoxin. In addition, K+ depolarization eliminated the sensitivity of carbamylcholine-stimulated phosphoinositide hydrolysis to the sodium channel blocker tetrodotoxin. Our results suggest that muscarinically stimulated phosphoinositide hydrolysis in rat cerebral cortex and heart atrium slices may occur by dual pathways which interact synergistically and that only one of the pathways is depolarization-dependent. Different muscarinic agonists could preferentially utilize these pathways, thus perhaps explaining their different potencies in stimulating phosphoinositide hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030414     DOI: 10.1021/bi00376a039

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  The inositol 1,4,5-trisphosphate pathway mediates cholinergic potentiation of rat hippocampal neuronal responses to NMDA.

Authors:  H Markram; M Segal
Journal:  J Physiol       Date:  1992-02       Impact factor: 5.182

2.  Role of calcium in regulation of phosphoinositide signaling pathway.

Authors:  J Patel; R A Keith; A I Salama; W C Moore
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

3.  Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells.

Authors:  M W MacCumber; C A Ross; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 4.  Formation of second messengers in response to activation of ion channels in excitable cells.

Authors:  F Gusovsky; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1988-06       Impact factor: 5.046

5.  Effect of prenatal treatment with methylazoxymethanol on carbachol-, norepinephrine- and glutamate-stimulated phosphoinositide metabolism in the neonatal, young, and adult offspring.

Authors:  W Balduini; G Lombardelli; G Peruzzi; F Cattabeni
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

6.  Regulation by batrachotoxin, veratridine, and monensin of basal and carbachol-induced phosphoinositide hydrolysis in neurohybrid NCB-20 cells.

Authors:  D M Chuang
Journal:  Neurochem Res       Date:  1990-07       Impact factor: 3.996

7.  Changes in extracellular calcium within the physiological range influence receptor-mediated inositol phosphate responses in brain and tracheal smooth muscle slices.

Authors:  J G Baird; E R Chilvers; E D Kennedy; S R Nahorski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

8.  Differences between muscarinic-receptor- and Ca2(+)-induced inositol polyphosphate isomer accumulation in rat cerebral-cortex slices.

Authors:  J G Baird; S R Nahorski
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

9.  Comparison of the effects of some muscarinic agonists on smooth muscle function and phosphatidylinositol turnover in the guinea-pig taenia caeci.

Authors:  A L Gardner; L K Choo; F Mitchelson
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  Cloned M1 muscarinic receptors mediate both adenylate cyclase inhibition and phosphoinositide turnover.

Authors:  R Stein; R Pinkas-Kramarski; M Sokolovsky
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.